$56.00
Today
as of Jul 22, 16:53 ET
Last 30 days
Recent Press Releases & News
Vaxcyte to Participate in Upcoming Investor Conferences
Vaxcyte Inc (PCVX) Is A Hidden Multibagger Stock To Buy Now
Vaxcyte Insider Sold Shares Worth $1,338,270, According to a Recent SEC Filing
Overview
52-week range
$29
$65
75% of range
Avg surprise (last 3)
-11.5%
Avg reaction (last 2)
+0.9%
50% positive
Latest IV / EM
56%
EM ±12.9% · $55 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $-2.30 | $-1.86 | -23.7% | -121.2% | +2.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.56 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $-1.22 | $-1.12 | -8.9% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $-1.04 | $-1.02 | -2.0% | — | -0.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.83 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1.10 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.85 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.91 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.70 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | OTHER | -$1.47 | -$1.22 | -20.5% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-346M | — | $-242M | $-226M | $-181M | — | $-140M | $-153M |
| Net income | $-321M | — | $-213M | $-167M | $-141M | — | $-103M | $-129M |
| EPS (diluted) | $-2.30 | — | $-1.56 | $-1.22 | $-1.04 | — | $-0.83 | $-1.10 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $261M | $174M | $281M | $307M | $347M | $388M | $1.05B | $519M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $1.81B | $1.63B | $1.77B | $1.72B | $1.72B | $1.79B | $2.21B | $1.48B |
| Total assets | $3.35B | $3.00B | $3.17B | $3.31B | $3.38B | $3.51B | $3.56B | $2.09B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $352M | $317M | $279M | $234M | $178M | $205M | $142M | $101M |
| Total equity | $3.00B | $2.69B | $2.89B | $3.07B | $3.20B | $3.31B | $3.42B | $1.99B |